Chris Gartin is a Managing Director in J.P. Morgan’s Healthcare Investment Banking Group, based in New York. As a client executive and key coverage partner, Chris is responsible for relationships with many of our clients in the biotechnology industry. Chris joined J.P. Morgan in 2021, having previously spent 12 years in Citi’s Global Healthcare Investment Banking Group covering biotechnology companies. Chris started his investment banking career in Lehman Brothers’ Global Healthcare Investment Banking Group. Chris received a Bachelor of Science in Business Administration from Georgetown University’s Robert McDonough School of Business. |